Lifesci Capital Initiates Coverage on Veradermics (NYSE:MANE)

Research analysts at Lifesci Capital started coverage on shares of Veradermics (NYSE:MANEGet Free Report) in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm set an “outperform” rating and a $135.00 price target on the stock. Lifesci Capital’s target price would indicate a potential upside of 43.95% from the company’s current price.

A number of other research firms have also recently commented on MANE. Wall Street Zen upgraded Veradermics from a “sell” rating to a “hold” rating in a research report on Sunday. Needham & Company LLC initiated coverage on shares of Veradermics in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $136.00 price target on the stock. Zacks Research raised shares of Veradermics to a “hold” rating in a research note on Tuesday, March 3rd. Citigroup raised their price target on shares of Veradermics from $120.00 to $135.00 and gave the company a “buy” rating in a research note on Monday, May 18th. Finally, Cantor Fitzgerald initiated coverage on shares of Veradermics in a research note on Monday, March 2nd. They issued an “overweight” rating on the stock. Six analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $114.20.

Read Our Latest Research Report on MANE

Veradermics Stock Down 2.6%

Shares of NYSE:MANE traded down $2.49 during trading on Tuesday, reaching $93.79. 164,986 shares of the company’s stock traded hands, compared to its average volume of 492,292. Veradermics has a fifty-two week low of $32.00 and a fifty-two week high of $117.71. The stock has a 50-day simple moving average of $90.99.

Veradermics (NYSE:MANEGet Free Report) last posted its earnings results on Tuesday, May 12th. The company reported ($1.32) EPS for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.76).

Veradermics Company Profile

(Get Free Report)

MANE is a global manufacturer and supplier of flavors, fragrances and ingredients for the food, beverage, personal care, household and fine fragrance markets. Headquartered in France, the company develops and produces aromatic solutions that are used by consumer goods companies, food processors, perfumers and formulators seeking sensory impact, taste modulation and olfactory character for their products.

The company’s product portfolio includes savory and sweet flavor systems, beverage concentrates, natural extracts, essential oils, fragrance compounds, cosmetic ingredients and specialty functional solutions such as taste enhancers and odor masking agents.

Recommended Stories

Analyst Recommendations for Veradermics (NYSE:MANE)

Receive News & Ratings for Veradermics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradermics and related companies with MarketBeat.com's FREE daily email newsletter.